Φορτώνει......
Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide
OBJECTIVE: Few studies have focused on investigating resistance mechanisms in myeloma immunotherapy. This study aimed to explore the relevant factor involved in the resistance of Elotuzumab and lenalidomide. METHODS: Cell models which are resistant to Elotuzumab and lenalidomide were constructed; di...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Onco Targets Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8071208/ https://ncbi.nlm.nih.gov/pubmed/33907421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S300328 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|